9 papers analyzed
Some studies suggest that treatments like topical cyclosporine and artificial tears are cost-effective for dry eye syndrome, while other studies highlight the substantial economic burden and high treatment costs associated with the condition.
Dry eye syndrome (DES) is a prevalent ocular condition characterized by insufficient tear production or excessive tear evaporation, leading to discomfort, visual disturbances, and potential damage to the ocular surface. The economic burden and cost-effectiveness of various treatments for DES are critical considerations for healthcare providers and policymakers.
Cost-Effectiveness of Topical Cyclosporine:
Efficacy and Safety of Topical Cyclosporine:
Cost-Effectiveness of Ophthalmic Lubricants:
Economic Burden of DES:
The treatment of dry eye syndrome, particularly with topical cyclosporine and ophthalmic lubricants, is generally cost-effective, providing significant improvements in quality of life for patients. However, the economic burden of DES remains substantial, highlighting the need for efficient management strategies to mitigate costs while ensuring effective patient care.
How much Fiber Supplements should I take daily?
How do ants communicate with each other?
Insurance and the war risks
Can eating well help with dementia?
are all the stars we see dead
Can creatine help with concussion recovery?